MedPath

insulin

Generic Name
insulin

Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

Phase 1
Completed
Conditions
COVID-19
Dysglycemia
Interventions
Drug: Subcutaneous Insulin
First Posted Date
2022-07-01
Last Posted Date
2024-08-01
Lead Sponsor
Benha University
Target Recruit Count
436
Registration Number
NCT05441631
Locations
🇪🇬

Banha University, Banhā, El- Qalyobia, Egypt

Topical Insulin Versus Autologous Serum After Corneal Surgeries

Phase 1
Conditions
Corneal Epithelial Wound
Interventions
Drug: autologous serum (AS)
Drug: conventional
First Posted Date
2022-04-18
Last Posted Date
2022-04-22
Lead Sponsor
Benha University
Target Recruit Count
250
Registration Number
NCT05331859
Locations
🇪🇬

Benha University, BaNHA, Egypt

🇪🇬

Ebsar Eye Centre, Banha, Kalyobeya, Egypt

Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.

Phase 2
Withdrawn
Conditions
Neurotrophic Keratitis
Interventions
Procedure: Tarsorrhaphy
First Posted Date
2022-04-11
Last Posted Date
2024-02-05
Lead Sponsor
University of Alberta
Registration Number
NCT05321251
Locations
🇨🇦

University of Toronto, Toronto, Ontario, Canada

🇨🇦

University of Alberta, Edmonton, Alberta, Canada

🇨🇦

University of British Columbia, Vancouver, British Columbia, Canada

and more 3 locations

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Recruiting
Conditions
Type1diabetes
Interventions
Device: Continuous glucose monitoring
Other: Premenstrual symptoms
Other: Ovulation kits
Device: Fitbit Inspire 2
Other: Keenoa
Other: Menstrual cycle
First Posted Date
2022-02-28
Last Posted Date
2024-08-21
Lead Sponsor
Institut de Recherches Cliniques de Montreal
Target Recruit Count
86
Registration Number
NCT05258292
Locations
🇨🇦

Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada

Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction

Early Phase 1
Completed
Conditions
Vasoconstriction
Insulin Resistance
Healthy
Interventions
First Posted Date
2022-02-17
Last Posted Date
2023-02-17
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
28
Registration Number
NCT05244694
Locations
🇺🇸

University of Missouri, Columbia, Missouri, United States

Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus

Phase 4
Completed
Conditions
Adverse Drug Event
Effect of Drug
Type 2 Diabetes Treated With Insulin
Interventions
First Posted Date
2021-12-17
Last Posted Date
2023-02-06
Lead Sponsor
Getz Pharma
Target Recruit Count
238
Registration Number
NCT05161741
Locations
🇵🇰

Social Security Hospital, Lahore, Punjab, Pakistan

Insulin Sensitivity After Breast Cancer

Not Applicable
Recruiting
Conditions
Insulin Sensitivity/Resistance
Breast Cancer
Survivorship
Metabolic Disturbance
Interventions
First Posted Date
2021-08-18
Last Posted Date
2021-08-18
Lead Sponsor
University of Copenhagen
Target Recruit Count
24
Registration Number
NCT05010356
Locations
🇩🇰

University of Copenhagen, Copenhagen, DK, Denmark

Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation

Not Applicable
Recruiting
Conditions
Kidney Transplant; Complications
Interventions
First Posted Date
2021-06-08
Last Posted Date
2023-07-18
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
40
Registration Number
NCT04918407
Locations
🇮🇷

SBMU, Tehran, Iran, Islamic Republic of

🇮🇷

Labbafinezhd Hospital, Tehran, Iran, Islamic Republic of

Comparative Effects of Metformin and Insulin on Stereological Studies and Immunohistochemistry of Placenta

Not Applicable
Completed
Conditions
Diabetes Mellitus in Pregnancy
Diabetes Mellitus Arising in Pregnancy, Insulin-Requiring
Interventions
First Posted Date
2021-06-01
Last Posted Date
2021-06-01
Lead Sponsor
University of Karachi
Target Recruit Count
156
Registration Number
NCT04907708
Locations
🇵🇰

Jinnah Post Graduate Medical Centre, Karachi, Sindh, Pakistan

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Other: Test to induce a decline in plasma glucose
Device: Dexcom G6
Other: Dex4
First Posted Date
2021-05-06
Last Posted Date
2023-08-31
Lead Sponsor
Institut de Recherches Cliniques de Montreal
Target Recruit Count
30
Registration Number
NCT04876079
Locations
🇨🇦

Montreal Clinical Research Institute, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath